Cwm, LLC Immuno Gen, Inc. Transaction History

Cwm, LLC

  • $23.3 Billion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024
BUY
$12.46 - $29.95 $1,657 - $3,983
133 Added 22.7%
719 $21,000
Q3 2023

Oct 11, 2023
BUY
$14.09 - $19.87 $4,522 - $6,378
321 Added 121.13%
586 $9,000
Q2 2023

Aug 03, 2023
SELL
$3.75 - $20.05 $555 - $2,967
-148 Reduced 35.84%
265 $5,000
Q1 2023

Apr 28, 2023
BUY
$3.67 - $4.92 $550 - $738
150 Added 57.03%
413 $2,000
Q4 2022

Feb 01, 2023
SELL
$4.55 - $6.31 $54 - $75
-12 Reduced 4.36%
263 $1,000
Q3 2022

Oct 27, 2022
BUY
$4.48 - $6.47 $407 - $588
91 Added 49.46%
275 $1,000
Q1 2022

Apr 21, 2022
SELL
$4.26 - $7.48 $29 - $52
-7 Reduced 3.66%
184 $1,000
Q4 2021

Jan 31, 2022
BUY
$4.75 - $7.5 $536 - $847
113 Added 144.87%
191 $1,000
Q4 2020

Sep 15, 2021
BUY
$3.7 - $7.66 $288 - $597
78 New
78 $1,000
Q4 2020

Jan 27, 2021
SELL
$3.7 - $7.66 $288 - $597
-78 Closed
0 $0
Q3 2020

Sep 15, 2021
BUY
$3.45 - $4.89 $269 - $381
78 New
78 $1,000
Q3 2020

Oct 19, 2020
SELL
$3.45 - $4.89 $269 - $381
-78 Closed
0 $0
Q2 2020

Sep 15, 2021
BUY
$3.32 - $5.34 $258 - $416
78 New
78 $1,000
Q2 2020

Jul 22, 2020
SELL
$3.32 - $5.34 $258 - $416
-78 Closed
0 $0
Q1 2020

Sep 15, 2021
BUY
$2.12 - $6.8 $165 - $530
78 New
78 $1,000
Q1 2020

Apr 28, 2020
SELL
$2.12 - $6.8 $165 - $530
-78 Closed
0 $0
Q4 2019

Sep 14, 2021
BUY
$2.25 - $5.8 $175 - $452
78 New
78 $1,000
Q4 2019

Jan 27, 2020
SELL
$2.25 - $5.8 $175 - $452
-78 Closed
0 $0
Q3 2019

Sep 14, 2021
BUY
$2.22 - $3.39 $173 - $264
78 New
78 $1,000
Q3 2019

Oct 22, 2019
SELL
$2.22 - $3.39 $173 - $264
-78 Closed
0 $0
Q2 2019

Sep 14, 2021
SELL
$1.8 - $3.3 $23 - $42
-13 Reduced 14.29%
78 $1,000
Q2 2019

Jul 31, 2019
BUY
$1.8 - $3.3 $23 - $42
13 Added 16.67%
91 $0
Q1 2019

Sep 02, 2021
BUY
$2.41 - $5.91 $187 - $460
78 New
78 $0
Q4 2018

Jan 25, 2019
SELL
$3.94 - $9.7 $102 - $252
-26 Closed
0 $0
Q2 2018

Jul 31, 2018
SELL
$9.52 - $12.15 $637 - $814
-67 Reduced 72.04%
26 $0
Q1 2018

Apr 26, 2018
BUY
$6.7 - $12.95 $623 - $1,204
93 New
93 $1,000

Others Institutions Holding IMGN

# of Institutions
8
Shares Held
1.41M
Call Options Held
0
Put Options Held
0
View Full List

About ImmunoGen, Inc.

IMGN Quotes by TradingView
  • Ticker IMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 220,712,992
  • Description
  • ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...
More about IMGN
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email